What numbers? They're definitely not looking at the...

What numbers? They're definitely not looking at the financials and sales growth. The clinical trial numbers are mediocre at best, and as for the covid trials they were bad results.
I'm still perplexed as to why Pfizer would buy this, only thing that makes sense is the years of data may be helpful with another of their initiatives, as Dx is not accurate enough, at best could be used for triage or telehealth. I thought they'd walk away if 13c was knocked back, holders should thank their lucky stars.